Table 1.
Prescription opioid formulations participants' (N=39) indicating they were currently taking.
| Prescription Opioid Brand Name (Generic Name) | Yes, n (%) |
|---|---|
| Oxycodone | 23 (59.0%) |
| Oxycontin (Oxycodone) | 19 (48.7%) |
| Percocet (Oxycodone/Acetaminophen) | 24 (61.5%) |
| Percodan (Oxycodone/Aspirin) | 5 (12.8%) |
| Roxicodone (Oxycodone Hydrochloride) | 6 (15.4%) |
| Tylox (Oxycodone/Acetaminophen) | 4 (10.3%) |
| Hydrocodone | 23 (59.0%) |
| Vicodin (Hydrocodone/Acetaminophen) | 18 (46.2%) |
| Lortab (Hydrocodone/Acetaminophen) | 30 (76.9%) |
| Hycodan (Hydrocodone/Homatropine Methylbromide) | 3 (7.7%) |
| Dolophine (Methadone Hydrochloride) | 3 (7.7%) |
| Morphine | 10 (25.6%) |
| Duramorph (Morphine) | 0 |
| Roxanol (Morphine Sulfate) | 1 (2.6%) |
| MS Contin (Morphine Sulfate) | 7 (17.9%) |
| Oramorph (Morphine) | 0 |
| Dilaudid (Hydromorphone Hydrochloride) | 8 (20.5%) |
| Fentanyl | 3 (7.7%) |
| Duragesic (Fentanyl) | 1 (2.6%) |
| Sublimaze (Fentanyl Citrate) | 0 |
| Actiq (Fentanyl) | 0 |
| Buprenorphine | 3 (7.7%) |
| Subutex (Buprenorphine) | 1 (2.6%) |
| Suboxone (Buprenorphine/Naloxone) | 4 (10.3%) |
| Buprenex (Buprenorphine Hydrochloride) | 0 |
| Codeine | 8 (20.5%) |
| Empirin (Aspirin/Codeine) | 0 |
| Tylenol 1, 2, or 3 (Acetaminophen/Codeine) | 5 (12.8%) |
| Demerol (Meperidine Hydrochloride) | 4 (10.3%) |
| Darvon (Propoxyphene) | 4 (10.3%) |